Abstract:Cataract, opacification of the lens, is one of the commonest causes of loss of useful vision during aging, with an estimated 16 million people world-wide affected. The role of nutritional supplementation in prevention of onset or progression of ocular disease is of interest to health care professionals and patients. The aging eye seems to be at considerable risk from oxidative stress. This review outlines the potential role of the new nutritional strategy on redox balance in age-related eye diseases and detail how the synergism and interaction of imidazole-containing amino acid-based compounds (nonhydrolized L-carnosine, histidine), chaperone agents (such as, L-carnosine, D-pantethine), glutathione-boosting agents (N-acetylcysteine, vitamin E, methionine), and N-acetylcarnosine eye drops plays key roles in the function and maintenance of the redox systems in the aging eye and in the treatment of human cataract disease. A novel patented oral health supplement is presented which enhances the anticataract activity of eye drops and activates functional visual acuity. The clinical data demonstrate the effectiveness and safety of a combined oral health care treatment with amino acids possessing chaperone-like activity with N-acetylcarnosine lubricant eye drops. L-carnosine and N-acetylcarnosine protected the chaperone activity of alpha-crystallin and reduced the increased posttranslational modifications of lens proteins. Biological activities of the nonhydrolyzed carnosine in the oral formulation are based on its antioxidant and antiglycating (transglycating) action that, in addition to heavy metal chelation and pH-buffering ability, makes carnosine an essential factor for preventing sight-threatening eye disorders having oxidative stress in their pathogenesis, neurodegeneration, and accumulation of senile features. The findings suggest that synergism is required between carnosine or other imidazole-containing compounds and reduced glutathione in tissues and cells for efficacious protection from protein carbonylation as a biomarker for the ability of the non-toxic compounds to reduce oxidative stress. Potential therapeutic applications of oral forms of nonhydrolized carnosine and their specific mechanisms to manage telomere attrition and vascular aging might help elderly patients to withstand the problems of sight-threatening eye diseases related to oxidative stress and accelerated biological ageing in linked with earlier onset of diseases.

[Chaperon-like anticataract agents, the antiaggregants of lens crystallin. Communication 4. Study of the effect of a mixture of di- and tetrapeptides on a prolonged rat model of UV-induced cataract]

[Search for chaperon-like anticataract drugs, the antiaggregants of lens crystallins. Communication. 1. Chaperon-like activity of N-acetyl carnosine dipeptide: in vitro study on a model of ultraviolet-induced aggregation of betaL-crystallin]

Natural dipeptides as mini-chaperones: molecular mechanism of inhibition of lens βL-crystallin aggregation

Pharmacological chaperone for α-crystallin partially restores transparency in cataract models

A native chemical chaperone in the human eye lens

Carnosine ameliorates lens protein turbidity formations by inhibiting calpain proteolysis and ultraviolet C-induced degradation

Peptide-based treatment strategies for cataract

Impediment of selenite-induced cataract in rats by combinatorial drug laden liposomal preparation

Freeze-dried liposomes as potential carriers for ocular administration of cytochrome <i>c</i> against selenite cataract formation

Lanosterol and 25-hydroxycholesterol dissociate crystallin aggregates isolated from cataractous human lens via different mechanisms.

Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation.

Protective Effect of VitC on Secondary Structure of Crystallin in Rat

The Chemopreventive Peptide Lunasin Inhibits D-Galactose- Induced Experimental Cataract in Rats

Research Progress of Molecular Recognition and Interaction of Crystallins Linking Cataract

In Vivo Substrates of the Lens Molecular Chaperones αA-Crystallin and αB-Crystallin

Advances in Pharmacotherapy of Cataracts

The Protective Effects of Aspirin on the Α-Crystalline Molecular Chaperone-Like Activity in Naphthalene-Induced Cataract

Lens epithelial cell protection by aminothiol WR-1065 and anetholedithiolethione from ionizing radiation